Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003259552 | SCV003944490 | uncertain significance | Inborn genetic diseases | 2023-03-15 | criteria provided, single submitter | clinical testing | The c.1265G>T (p.R422L) alteration is located in exon 8 (coding exon 8) of the CYP11B1 gene. This alteration results from a G to T substitution at nucleotide position 1265, causing the arginine (R) at amino acid position 422 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005047490 | SCV005675051 | uncertain significance | Deficiency of steroid 11-beta-monooxygenase; Glucocorticoid-remediable aldosteronism | 2024-01-10 | criteria provided, single submitter | clinical testing |